Skip to main content
Overview
Company Profile
News
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Financials
Annual Reports
SEC Filings
Governance
Governance Documents
Executive Management
Committee Composition
Resources
Information Request Form
Investor Emails Alerts
Investor Contacts
Toggle navigation
Menu
SEARCH
×
News
Overview
Company Profile
News
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Financials
Annual Reports
SEC Filings
Governance
Governance Documents
Executive Management
Committee Composition
Resources
Information Request Form
Investor Emails Alerts
Investor Contacts
×
Normal
Press release year list
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
12/13/2021
New Study Suggests That Masimo SedLine® Brain Function Monitoring May Aid Early Identification of Patients at Risk of Developing Postoperative Delirium
11/29/2021
Masimo Rad-G® Helps Clinicians Identify Pediatric Pneumonia in Large Field Trial in India
11/23/2021
Masimo to Present in Piper Sandler 33rd Annual Healthcare Conference
11/15/2021
New Study Finds That Use of Masimo SedLine® PSi and DSA May Significantly Reduce Postoperative Delirium
11/11/2021
Masimo to Present in Stifel 2021 Virtual Healthcare Conference
11/08/2021
Masimo Root® with a Multimodal Brain Monitoring Algorithm May Improve Postoperative Neurocognition in Elderly Patients
11/01/2021
Masimo Launches Dual SET® Pulse Oximetry
10/26/2021
Masimo Reports Third Quarter 2021 Financial Results
10/18/2021
New Study Recommends the Use of Masimo PVi® to Guide Fluid Administration During Major Oncosurgery with Lung Ultrasonography
10/12/2021
Masimo to Report Third Quarter 2021 Financial Results After Market Close on Tuesday, October 26
10/04/2021
Masimo and University Hospitals Partner to Combat Nurse Burnout
09/26/2021
New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically Ventilated Neonates
09/22/2021
Masimo CEO Joe Kiani Appointed to President’s Council of Advisors on Science and Technology
09/13/2021
Masimo Launches Single-patient-use rainbow® SuperSensor™
09/08/2021
Masimo to Present in Morgan Stanley 19th Annual Global Healthcare Conference
09/06/2021
New Study Investigates the Ability of Masimo ORi™ to Provide Early Warning of Hypoxemia During Endotracheal Intubation in ICU Patients
08/31/2021
Masimo Partners with Penington Institute to Raise Awareness of Harm from Prescription Opioid Overdose
08/30/2021
Masimo SafetyNet Alert™ Launches in Western Europe
08/26/2021
Society for the Advancement of Patient Blood Management (SABM) Publication Recommends Continuous Hemoglobin Monitoring
08/23/2021
New Study Evaluates the Use of Masimo PVi® to Monitor Volume Status in Spontaneously Breathing Hemodialysis Patients
08/16/2021
New Study Evaluates the Use of Masimo Bridge® As an Alternative to Opioids
07/27/2021
Masimo Reports Second Quarter 2021 Financial Results
07/19/2021
Masimo Introduces the MX-7™ rainbow SET® Technology Board for Original Equipment Manufacturing Partners
07/13/2021
Masimo to Report Second Quarter 2021 Financial Results after Market Close on Tuesday, July 27
07/06/2021
New Study Evaluates the Ability of Masimo SedLine® Brain Function Monitoring to Predict Neurological Outcomes and Long-term Survival in Post-Cardiac Arrest ICU Patients
06/21/2021
Masimo Announces FDA 510(k) Clearance of Radius Tº™ for Prescription and Over-the-Counter (OTC) Use
06/14/2021
New Study Investigates the Impact of ORi-Guided Oxygen Titration on Hyperoxemia-Mediated Morbidity During One-Lung Ventilation
05/19/2021
Masimo to Present in UBS Global Healthcare Virtual Conference
05/17/2021
New Study Assesses the Effects of Masimo Patient SafetyNet™ on Nursing Workflows in the General Ward
05/13/2021
Spacelabs Healthcare Partners With Masimo to Bring Advanced Measurements to Spacelabs Patient Monitors
05/10/2021
Study Investigates the Ability of Masimo O3® to Aid in Monitoring Septic Shock ICU Patients and Predicting Mortality
05/03/2021
Study Investigates the Ability of Masimo PVi® to Predict Preload Responsiveness in Patients On Nasal High-Flow Therapy
04/26/2021
Masimo Reports First Quarter 2021 Financial Results
04/19/2021
Masimo Reschedules Date of First Quarter 2021 Financial Results Conference Call
04/14/2021
Masimo to Report First Quarter 2021 Financial Results after Market Close on Tuesday, April 27
04/12/2021
Masimo Announces FDA Clearance of Radius PCG™ for the Root® Patient Monitoring and Connectivity Platform
04/06/2021
Masimo to Present in 20th Annual Needham Healthcare Conference
04/06/2021
Study Investigates the Effects of Ventilatory Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients Using Masimo O3®
03/29/2021
Study Investigates the Impact of Automating Respiration Rate Measurement Using Masimo Rad-G™ with RRp®
03/22/2021
Sri Lankan Study Expands Evidence Demonstrating the Benefits of Critical Congenital Heart Disease (CCHD) Screening Using Masimo SET® Pulse Oximetry
03/15/2021
New Study Evaluates the Ability of Masimo EMMA® Capnography to Assess the Respiratory Status of Children With Tracheostomy
03/08/2021
Masimo Monitoring Solutions Promote Newborn and Maternal Safety
03/02/2021
Masimo Announces CE Marking of the Rad-G™ with Temperature
02/24/2021
Masimo to Present in Raymond James 42nd Annual Institutional Investors Conference
02/23/2021
Masimo Reports Fourth Quarter and Full-Year 2020 Financial Results
02/23/2021
Masimo Announces U.S. Release of softFlow® High-Flow Nasal Cannula Therapy
02/16/2021
Masimo to Report Fourth Quarter and Full Year 2020 Financial Results after Market Close on Tuesday, February 23
02/15/2021
Masimo Announces Full Market Release of Masimo SafetyNet-OPEN™
02/10/2021
Masimo to Present in BTIG MedTech and Digital Health Conference
02/02/2021
Masimo Expands Suite of Advanced Measurements Through Acquisition of UK-Based LiDCO Group Plc
01/19/2021
Masimo Announces the iSirona™ Connectivity Hub
01/13/2021
Masimo Announces Select Preliminary Full-Year 2020 Financial Results and 2021 Guidance